Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), Rx Only, 100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each) per carton, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in India, NDC 51079-443-20.
Class II · Ongoing
Super-Potent Drug: Out of specification potency results were obtained.
Advertisement
Advertisement
Affected lots / codes — check yours against thisLot 3115773, Exp. 03/31/2025
- Recalling firm
- Mylan Institutional, Inc., Rockford, IL
- Classification
- Class II (temporary or reversible harm possible)
- Status
- Ongoing
- Quantity
- 1,068 cartons
- Distribution
- Nationwide in the USA
- Recall initiated
- March 7, 2025
- Classified
- March 20, 2025
- Initiation
- Voluntary: Firm initiated
Advertisement
Official source. This record is published by the U.S. FDA through the openFDA
enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0291-2025%22
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0291-2025%22
Advertisement
Important. Recalls target specific lots and codes — compare the affected lots
above against your own product. This page reproduces public FDA data for readability;
EveryRecall is independent and not affiliated with the FDA.
Check this brand across all 8 databases →